- Home
- AGS vs DCTH Comparison
AGS vs DCTH Comparison
Compare AGS & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGS
- DCTH
- Stock Information
- Founded
- AGS 2005
- DCTH 1988
- Country
- AGS United States
- DCTH United States
- Employees
- AGS N/A
- DCTH N/A
- Industry
- AGS Miscellaneous manufacturing industries
- DCTH Medical/Dental Instruments
- Sector
- AGS Consumer Discretionary
- DCTH Health Care
- Exchange
- AGS Nasdaq
- DCTH Nasdaq
- Market Cap
- AGS 485.4M
- DCTH 398.2M
- IPO Year
- AGS 2018
- DCTH N/A
- Fundamental
- Price
- AGS $11.84
- DCTH $14.31
- Analyst Decision
- AGS Hold
- DCTH Strong Buy
- Analyst Count
- AGS 4
- DCTH 4
- Target Price
- AGS $12.63
- DCTH $22.25
- AVG Volume (30 Days)
- AGS 265.8K
- DCTH 411.6K
- Earning Date
- AGS 03-04-2025
- DCTH 11-08-2024
- Dividend Yield
- AGS N/A
- DCTH N/A
- EPS Growth
- AGS 150.52
- DCTH N/A
- EPS
- AGS 0.17
- DCTH N/A
- Revenue
- AGS $386,033,000.00
- DCTH $22,644,000.00
- Revenue This Year
- AGS $10.87
- DCTH $1,605.13
- Revenue Next Year
- AGS $4.33
- DCTH $111.67
- P/E Ratio
- AGS $69.80
- DCTH N/A
- Revenue Growth
- AGS 12.18
- DCTH 945.91
- 52 Week Low
- AGS $7.97
- DCTH $3.70
- 52 Week High
- AGS $11.91
- DCTH $14.47
- Technical
- Relative Strength Index (RSI)
- AGS 67.92
- DCTH 70.27
- Support Level
- AGS $11.51
- DCTH $12.14
- Resistance Level
- AGS $11.91
- DCTH $12.98
- Average True Range (ATR)
- AGS 0.08
- DCTH 0.77
- MACD
- AGS 0.03
- DCTH 0.16
- Stochastic Oscillator
- AGS 85.42
- DCTH 95.12
About AGS PlayAGS Inc.
PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.